跳至主要内容
临床试验/NCT01041066
NCT01041066Unknown不适用

Nicardipine Versus Labetalol During Intubation

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
70
试验地点
1
主要终点
hemodynamic variables (systolic blood pressure, diastolic blood pressure and mean blood pressure, heart rate)

研究概览

简要总结

The aim of this study was to compare the efficacy of nicardipine and labetalol in attenuation of cardiovascular responses to endotracheal intubation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for general anesthesia with endotracheal intubation

排除标准

  • Patients with heart failure or coronary artery disease 2-3 degree atrio-ventricular block or severe bradycardia (< 45 beats/min) asthma, bronchial spasm or chronic obstructive pulmonary disease patients with anticipated difficult intubation (Mallampati class III, IV) severe hepatic or renal dysfunction allergy or contraindication to study medication

研究组 & 干预措施

group L

Active Comparator

0.4 mg/kg labetalol

干预措施: labetalol (Drug)

group N

Active Comparator

20 ㎍/kg nicardipine

干预措施: nicardipine (Drug)

结局指标

主要结局

hemodynamic variables (systolic blood pressure, diastolic blood pressure and mean blood pressure, heart rate)

时间窗: preinduction- 10 min after intubation

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验